CN1244373C - 一种治疗胆囊炎的中药组合物及其制备方法 - Google Patents
一种治疗胆囊炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1244373C CN1244373C CNB2004100437062A CN200410043706A CN1244373C CN 1244373 C CN1244373 C CN 1244373C CN B2004100437062 A CNB2004100437062 A CN B2004100437062A CN 200410043706 A CN200410043706 A CN 200410043706A CN 1244373 C CN1244373 C CN 1244373C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 39
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 210000003038 endothelium Anatomy 0.000 claims abstract description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000014375 Curcuma Nutrition 0.000 claims abstract 3
- 241000612166 Lysimachia Species 0.000 claims abstract 2
- 241000207929 Scutellaria Species 0.000 claims abstract 2
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 9
- 239000010271 massa medicata fermentata Substances 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 241001529553 Scoparia <angiosperm> Species 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 abstract description 25
- 239000000052 vinegar Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 18
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 241000132012 Atractylodes Species 0.000 abstract 2
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 2
- 240000007551 Boswellia serrata Species 0.000 abstract 2
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 2
- 241000202726 Bupleurum Species 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 240000007311 Commiphora myrrha Species 0.000 abstract 2
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 2
- 244000164480 Curcuma aromatica Species 0.000 abstract 2
- 241000234653 Cyperus Species 0.000 abstract 2
- 235000002848 Cyperus flabelliformis Nutrition 0.000 abstract 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 25
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 210000000232 gallbladder Anatomy 0.000 description 18
- 230000017531 blood circulation Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 241000209094 Oryza Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 239000007921 spray Substances 0.000 description 9
- 230000004087 circulation Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000000994 depressogenic effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000000941 bile Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 2
- 206010018045 Gastroptosis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010008616 Cholecystitis and cholelithiasis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 241000590988 Danainae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057969 Reflux gastritis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000387 litholytic effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗胆囊炎的中药组合物,由白芍、金钱草、郁金、柴胡、赤芍、丹参、元胡、麸枳壳、炒山楂、木香、茵陈、黄芩、厚朴、神曲、丹皮、香附、虎杖、莱菔子、内金、川楝子、焦白术、乳香、没药、青皮、大黄共25味中药组成;其制备方法是将组方中的白芍、郁金、柴胡、赤芍、丹参、元胡、香附、内金、乳香、乳香、没药、青皮是经醋制后入药,具体是将上述每种药物单独用醋喷淋、闷透,然后用文火炒制后,按方称量;枳壳、山楂、川楝子、白术经炒制后,按方称量入药;其余各味药直接称量与上述各味中药混合后一起制成粉。本发明组方合理、疗效显著、治愈后不复发。
Description
技术领域:
本发明涉及的是一种治疗胆囊炎的中药组合物及其制备方法。
背景技术:
胆囊炎是临床较为常见的多发病,其发病也因较为复杂,虽有慢性和急性之分,但其病因多为肝胆郁滞,湿热蕴结或饮食不当、情志失调,肝气郁结、劳累过渡而使肝胆、脾胃不和,郁积而发湿热,致使胆囊发病。胆囊炎在中医称为“胆涨”“胆郁”,治疗组方多为疏肝利胆,清热利湿。在西医治疗中多是以消炎为主,严重时则手术将胆囊切除,术后胆汁直接排入肠道,其临床效果并不理想,常会在术后引发其它病症,如消化不良,胆汁排入肠道可诱发结肠癌。采用中药组方治疗急、慢性胆囊炎也有许多,主要是从湿(内湿)、热(肝经之火)、郁(气郁)、瘀(血瘀)、虚(阴虚、脾虚)5个方面考虑组方,因此,每个中药组合物组方都有其独到之处。
发明内容:
本发明的目的是提供一种治疗胆囊炎的中药组合物及其制备方法,针对胆囊病慢性化、反复发作,采取以治疗瘀血、郁热为主的治疗方法,使变性的粘膜与胆囊壁血管得到一定程度的改善,为胆囊炎患者解除病痛。
实现上述发明目的技术方案是:一种治疗胆囊炎的中药组合物以治疗瘀血、胆郁为主(主要是瘀血、郁热),由白芍、金钱草、郁金、柴胡、赤芍、丹参、元胡、麸枳壳、炒山楂、木香、茵陈、黄芩、厚朴、神曲、丹皮、香附、虎杖、莱菔子、内金、川楝子、焦白术、乳香、没药、青皮、大黄共25味中药组成;组方中各味中药的重量配比为:白芍5-10份、金钱草10-15份、郁金10-15份、柴胡5-10份、赤芍5-7份、丹参5-8份、元胡5-7份、麸枳壳7-8份、炒山楂7-8份、木香5-8份、茵陈5-8份、黄芩5-7份、厚朴7-8份、神曲7-8份、丹皮5-7份、香附5-8份、虎杖5-7份、莱菔子5-7份、内金7-8份、川楝子5-6份、焦白术5-8份、乳香5-7份、没药5-7份、青皮5-8份、大黄5-6份。
一种治疗胆囊炎的中药组合物的制备方法是:组方中的白芍、郁金、柴胡、赤芍、丹参、元胡、香附、内金、乳香、乳香、没药、青皮是经醋制后入药,具体是将上述每种药物单独用醋喷淋、闷透,然后用文火炒制后,按方称量;枳壳、山楂、川楝子、白术经炒制后,按方称量入药;其余各味药直接称量与上述各味中药混合后一起制成粉。
上述组方中:白芍养血敛阴、柔肝止痛,平抑肝阳,用醋炒制后增强入肝、收敛疏肝、解郁作用;金钱草内含胆碱、钾盐等,并有促进胆汁从胆管排出,且能排石,具有消肿软坚、利胆退黄,尤其对金黄色葡萄球菌有抑制作用;郁金活血、止痛、行气、解郁、凉血、清心利胆、退黄,促进胆汁分泌和排泄,尤其对泥沙样结石有效,用醋炒制后增强舒肝止痛作用;柴胡和解退热、疏肝解郁、升举阳气,用醋炒制后缓和辛烈之性,增强疏肝止痛、开郁作用。上述四味中药组成君药,具有疏肝止痛、理气、活血、解郁、清热作用。
木香具有行气止痛、调中的作用;香附疏肝理气、调经止痛,用醋炒制后增强疏肝止痛并消积、化滞入肝经作用;枳壳破气消积、化痰、除痞、行气、宽中、除胀,炒制成麸枳壳后具有缓和辛燥之性,增强理气和脾、除胀作用;厚朴燥湿除满、行气降逆;青皮疏肝、破气、散结、消滞,可使胆汁中酸含量增加,用醋炒制后具有缓和辛燥之性,增强止痛、消积、化滞作用;川楝子行气止痛,炒制后缓和苦寒之性,降低其毒性,增强疏肝止疼、理气作用;大黄泻下攻积、清热泻火、解毒、活血祛瘀,并由降低胆固醇作用;黄芩清热燥湿、泻火解毒、止血安胎;丹皮清热、凉血、散瘀,用醋炒制后增强活血止疼、清热凉血、入肝作用;赤芍清热凉血、祛瘀止疼;丹参活血祛瘀、凉血消痛,养血安神,具有明显抑制胆囊、胆管纤维化作用,醋制后增强活血祛瘀、止疼作用;元胡活血、行气止疼,醋制后增强行气止疼作用和蒸出有效成分;虎杖清热解毒、利湿、退黄、活血止痛,化痰止咳;乳香、没药活血止疼、消肿,醋制后缓和刺激性,增强活血止疼、收敛生肌作用并矫气味;上述各味中药组成臣药。
山楂消食化积、活血化瘀,炒制后减弱其酸性,缓和对胃的刺激性,增强消食化积作用;神曲消食和胃,莱菔子消食化积、降气化痰;白术补气健脾、燥湿利水、止汗安胎,炒制成焦白术增强健脾作用,缓和其燥性;鸡内金具有消石积、化结石,涩精止遗、运脾;上述各味中药在方中为佐药。
柴胡作为使药和解退热、舒肝解郁、开阳举气,以大黄泻下攻积清热、泻火解毒、活血祛瘀。
以上君、臣、佐、使各味中药配伍,共同发挥疏肝、行气解郁、活血止痛、化瘀、通腑利胆、消石、排石、溶石的功效。
上述组方以散剂为主或灌装胶囊,每次饭后服用,每日三次,连服一个月为一个疗程。开始服用四天后可每次加服油煎鸡蛋,如病情较重,患病时间较长,可每天一次静点5%糖+黄芪4支(上海)、丹参8支(上海),连用7-14天为1个疗程,进行辅助治疗,抗纤维化或减少反复发作。散剂用量每次5-10g,胶囊每次5粒,每粒1-2g。
上述组方服用后总有效率为97.9%。
药物禁忌:气恼、胃下垂、孕妇、劳累,服后有轻微腹痛现象。
上述组方用于治疗各种急、慢性胆囊炎、胆结石、胆管炎、胆汁返流性胃炎、胆道蛔虫、胰腺炎及胆道术后综合症、胆心综合症。
本发明具有的优点和积极效果:组方合理、疗效显著、治愈后不复发。
具体实施方式:
实施例1:治疗胆囊炎的中药组合物组方如下:
白芍50g(5份)、金钱草100g(10份)、郁金100g(10份)、柴胡50g(5份)、赤芍50g(5份)、丹参50g(5份)、元胡50g(5份)、麸枳壳70g(7份)、炒山楂70g(7份)、木香70g(7份)、茵陈50g(5份)、黄芩50g(5份)、厚朴70g(7份)、神曲70g(7份)、丹皮50g(5份)、香附70g(7份)、虎杖50g(5份)、莱菔子70g(7份)、内金70g(7份)、川楝子50g(5份)、焦白术50g(5份)、乳香50g(5份)、没药50g(5份)、青皮70g(7份)、大黄50g(5份)。
制备方法:1、醋制:白芍用米醋喷淋、拌匀、闷透,温火炒制呈黄色;郁金用米醋喷淋、闷透,文火炒制微干;柴胡用米醋喷淋、拌匀、闷透,文火炒制黄色;丹参用米醋喷淋、闷透,文火炒制微干;元胡用米醋喷淋、闷透,文火炒制微黄火色;丹皮用米醋喷淋、闷透,文火炒制微黄色;香附用米醋拌匀、闷透,文火炒制微黄色、透出香气;乳香用米醋喷淋、拌匀,用文火炒制表面发亮;没药用米醋喷淋、拌匀,用文火炒制表面发亮;青皮用米醋拌匀、闷透,用文火炒制微黄色、透出香气;
2、炒制:枳壳先将锅用文火烧热,撒入麸皮,冒烟时加入枳壳,快炒见深黄色取出,也可直接购买市售成品;山楂用文火加热,炒制淡黄火色;川楝子放入锅内用文火加热,炒制表面呈深黄火色;白术放入锅内用文火加热,炒制表面呈焦黄火色;
3、上述经醋制和炒制的中药与余下的中药按组方称量后混合后制成粉,按每次服用量装包、袋或装囊。
临床效果:采用对比试用、观察疗效,病例服药前由正规医院确诊。
治疗组:病例共1470例,其中:男性患者490例,女性患者980例,年龄22-70岁,平均年龄41岁,病程1-15年。服用本发明组方,每日3次,每次5g。
对比组:病例共500例,其中:男性患者300例,女性患者200例,年龄23-73岁,病程1.3-15年。服用药物:常规服用中成药胆舒,每次2粒,每日3次,辅助消炎药头拉定,每次0.5g,每日3次或阿莫西林每次0.5g,每日3次。
上述两组用药时间以1个月为一个疗程,连服2个月,服药期间停服任何治疗胆囊炎药物,禁忌劳累、气恼、禁酒。
判定标准:临床治愈症状和体征消失,B超检查胆囊大小正常,胆囊壁光滑,无增厚、无胆汁淤积、无结石,随访2年无发作、显效症状和体证消失;B超检查胆囊大小正常,胆囊壁光滑、无增厚、无胆汁淤积,2年无发作,有效症状和体征基本消失;B超检查胆囊大小、胆囊壁毛糙等有明显改善,1年内偶有发作,无效治疗,2个疗程无改善。
效果对比:
临床观察效果对比表
由表可见:治疗组治愈率及总有效率均明显高于对照组,表明该药物治疗胆囊炎及胆结石疗效满意,其中30例中有5例因胃下垂而中断治疗,其余25例未按要求服药。
Claims (2)
1、一种治疗胆囊炎的中药组合物,其特征是:由白芍、金钱草、郁金、柴胡、赤芍、丹参、元胡、麸枳壳、炒山楂、木香、茵陈、黄芩、厚朴、神曲、丹皮、香附、虎杖、莱菔子、内金、川楝子、焦白术、乳香、没药、青皮、大黄共25味中药组成;组方中各味中药的重量配比为:白芍5-10份、金钱草10-15份、郁金10-15份、柴胡5-10份、赤芍5-7份、丹参5-8份、元胡5-7份、麸枳壳7-8份、炒山楂7-8份、木香5-8份、茵陈5-8份、黄芩5-7份、厚朴7-8份、神曲7-8份、丹皮5-7份、香附5-8份、虎杖5-7份、莱菔子5-7份、内金7-8份、川楝子5-6份、焦白术5-8份、乳香5-7份、没药5-7份、青皮5-8份、大黄5-6份。
2、一种治疗胆囊炎的中药组合物,其特征是:组方中各味中药的重量配比为:白芍5份、金钱草10份、郁金10份、柴胡5份、赤芍5份、丹参5份、元胡5份、麸枳壳7份、炒山楂7份、木香7份、茵陈5份、黄芩5份、厚朴7份、神曲7份、丹皮5份、香附7份、虎杖5份、莱菔子7份、内金7份、川楝子5份、焦白术5份、乳香5份、没药5份、青皮7份、大黄5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100437062A CN1244373C (zh) | 2004-07-12 | 2004-07-12 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100437062A CN1244373C (zh) | 2004-07-12 | 2004-07-12 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1593601A CN1593601A (zh) | 2005-03-16 |
| CN1244373C true CN1244373C (zh) | 2006-03-08 |
Family
ID=34665403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100437062A Expired - Fee Related CN1244373C (zh) | 2004-07-12 | 2004-07-12 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1244373C (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100340284C (zh) * | 2005-08-03 | 2007-10-03 | 孙润古 | 金胆溶石胶囊 |
| CN100340285C (zh) * | 2005-09-21 | 2007-10-03 | 马云翔 | 治疗胆结石的药物及其制备方法 |
| CN101579413B (zh) * | 2008-05-15 | 2011-04-20 | 北京北大维信生物科技有限公司 | 一种治疗胆结石的药物组合物及其制备方法 |
| CN101658657B (zh) * | 2009-08-25 | 2011-05-11 | 路正平 | 一种用于治疗慢性胆囊炎的药物 |
| CN102579973B (zh) * | 2012-02-02 | 2013-09-18 | 陈中元 | 一种治疗胆结石的药物 |
| CN102626498B (zh) * | 2012-04-06 | 2013-08-14 | 王建设 | 治疗慢性胰腺炎的前苓赤金汤 |
| CN102671124B (zh) * | 2012-05-17 | 2013-10-30 | 王光华 | 一种治疗胆红素结石的药物及其制备方法 |
| CN102727633B (zh) * | 2012-07-20 | 2014-03-19 | 成都中医药大学 | 一种治疗慢性乙型肝炎的药物组合物及其制备方法和用途 |
| CN103110905B (zh) * | 2013-03-18 | 2015-05-27 | 山东大学 | 一种治疗肝郁脾虚型胆囊炎的中药制剂 |
| CN103316174B (zh) * | 2013-07-10 | 2015-01-21 | 朱克兰 | 一种治疗急性胆囊炎的中药组合物及其制备方法 |
| CN103495116B (zh) * | 2013-09-29 | 2015-08-19 | 都匀文学诊所 | 治疗肝内胆管结石的中药 |
| CN103656271A (zh) * | 2013-11-21 | 2014-03-26 | 杨莉 | 一种治疗慢性胆囊炎中药组合物 |
| CN105688034A (zh) * | 2014-02-11 | 2016-06-22 | 青岛华之草医药科技有限公司 | 一种中药组合物在制备治疗胆囊切除术后综合征的药物中的应用 |
| CN104258288A (zh) * | 2014-10-08 | 2015-01-07 | 济南高达信息技术有限公司 | 一种治疗胆管炎的中药颗粒剂及其制备方法 |
| CN104623557A (zh) * | 2015-02-27 | 2015-05-20 | 陈守强 | 一种治疗胆心综合征的中药及制备方法 |
| CN104758735A (zh) * | 2015-03-26 | 2015-07-08 | 孙红梅 | 一种治疗胆囊炎的中药组合物 |
| CN108404036A (zh) * | 2017-02-09 | 2018-08-17 | 董育铭 | 消炎止痛通络汤 |
-
2004
- 2004-07-12 CN CNB2004100437062A patent/CN1244373C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1593601A (zh) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101224287B (zh) | 一种治疗痤疮的内服中药及其制备方法 | |
| CN1244373C (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
| CN1151806C (zh) | 治疗胆囊炎胆结石、胰腺炎、黄疸性肝炎的胶囊 | |
| CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
| CN104127531A (zh) | 一种治疗肠胃炎的中药组合物及其制备方法 | |
| CN101062372A (zh) | 治疗肝胆道系统结石的溶石性中药制剂 | |
| CN101658657B (zh) | 一种用于治疗慢性胆囊炎的药物 | |
| CN104524335A (zh) | 一种用于女性内分泌失调调理的药丸及制备方法 | |
| CN102657795A (zh) | 一种促进术后刀口愈合的中药制剂 | |
| CN107115493A (zh) | 一种治疗骨折的中药组合物及其制备方法和用途 | |
| CN105311492A (zh) | 一种用于冠状动脉粥样硬化性心脏病的药物 | |
| CN101239134A (zh) | 祛斑药物组合物 | |
| CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
| CN104873911A (zh) | 一种辅助治疗脓毒症的内服中药 | |
| CN105456924A (zh) | 含有艾叶的具有活血化瘀功能的中药制剂及其制备方法 | |
| CN104042839A (zh) | 一种治疗花斑癣的中药组合物 | |
| CN1286500C (zh) | 治疗关节疼痛的药物 | |
| CN104623544A (zh) | 中度脂肪肝健脾燥湿中药剂及制备方法 | |
| CN103028058B (zh) | 一种治疗乏力的中药组合物 | |
| CN101167915B (zh) | 治疗慢性浅表性胃炎的中药组合物及其制备方法 | |
| CN101983712A (zh) | 冠心病的新型治疗药物 | |
| CN101554426B (zh) | 一种治疗糖尿病性顽固便秘的中药 | |
| CN105327066A (zh) | 一种制备治疗产后缺乳的中药组合物的方法 | |
| CN1171621C (zh) | 血脉通及其制作方法 | |
| CN103735665A (zh) | 一种治疗月经不调的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060308 Termination date: 20110712 |
